Summary:
This index was incorporated January 1, 2003. It initially was a collection of 15 stocks from around the world that the StemClone Digest values as important to the field of stem cell, cloning, and cell transplantation research and medicine.
Visit SCCC Index.

Description (Web site quote):
It is important to note that this field of medical research is still in its infancy. There will be many changes, some good, some awful, before this field becomes fully acceptable financially, and more importantly, medically.

However, the StemClone Digest will use this index in an attempt to gauge the performance of stem cell and cloning stocks against the rest of the biotechnology indeces, hopefully providing a clear picture of the growth of this young, albeit growing, industry.
Visit SCCC Index.